GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.180
+0.140 (4.61%)
Jun 11, 2025, 4:00 PM - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $8.22 million as of June 12, 2025. Its market cap has increased by 3.63% in one year.
Market Cap
8.22M
Enterprise Value
5.86M
1-Year Change
3.63%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $8.22M, a decrease of -99.12%. That is a compound annual growth rate of -10.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.59B |
| Johnson & Johnson | 373.49B |
| AbbVie | 334.13B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.04B |
| Abbott Laboratories | 232.09B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |